Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
20587.5%
operating margin TTM
-20802.25%
revenue TTM
7.42 Million
revenue per share TTM
0.14$
valuation ratios | |
|---|---|
| pe ratio | 3.45 |
| peg ratio | 0.06 |
| price to book ratio | 1.66 |
| price to sales ratio | 710.58 |
| enterprise value multiple | 3.82 |
| price fair value | 1.66 |
profitability ratios | |
|---|---|
| gross profit margin | -241.0% |
| operating profit margin | -20802.25% |
| pretax profit margin | 20666.25% |
| net profit margin | 20587.5% |
| return on assets | 35.63% |
| return on equity | 78.38% |
| return on capital employed | -39.83% |
liquidity ratios | |
|---|---|
| current ratio | 9.74 |
| quick ratio | 9.53 |
| cash ratio | 3.75 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 1,297.84 |
| operating cycle | 2,772.44 |
| days of payables outstanding | 1,586.04 |
| cash conversion cycle | 1,186.40 |
| receivables turnover | 0.25 |
| payables turnover | 0.23 |
| inventory turnover | 0.28 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.10 |
| debt equity ratio | 0.14 |
| long term debt to capitalization | 0.06 |
| total debt to capitalization | 0.12 |
| interest coverage | -21.13 |
| cash flow to debt ratio | -3.11 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.52 |
| cash per share | 3.82 |
| operating cash flow per share | -1.38 |
| free cash flow operating cash flow ratio | 1.10 |
| cash flow coverage ratios | -3.11 |
| short term coverage ratios | -8.33 |
| capital expenditure coverage ratio | -10.09 |
Frequently Asked Questions
When was the last time Abeona Therapeutics Inc. (NASDAQ:ABEO) reported earnings?
Abeona Therapeutics Inc. (ABEO) published its most recent earnings results on 12-11-2025.
What is Abeona Therapeutics Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Abeona Therapeutics Inc. (NASDAQ:ABEO)'s trailing twelve months ROE is 78.38%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Abeona Therapeutics Inc. (ABEO) currently has a ROA of 35.63%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ABEO's net profit margin stand at?
ABEO reported a profit margin of 20587.5% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ABEO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 9.74 in the most recent quarter. The quick ratio stood at 9.53, with a Debt/Eq ratio of 0.14.